Markers to Evaluate the Efficacy of PH-based Regimen as a Neoadjuvant Therapy for Operable HER2 Positive Breast Cancer

NCT04281641 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
94
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Fudan University